University of Maryland School of Medicine, United States
Disclosure information not submitted.
A novel immune-stimulator antibody conjugate (ISAC) against CD47 for cancer immunotherapy
Thursday, October 24, 2024
8:30 AM – 8:45 AM EST
Thursday, October 24, 2024
9:15 AM – 9:30 AM EST
Protein Nanocage-Based Immunomodulatory Strategies to Enhance Immunotherapy for Glioblastoma
Saturday, October 26, 2024
1:00 PM – 1:15 PM EST